- Home
- GH
GH
Guardant Health Inc.
as 04-18-2025 1:36pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | N/A | IPO Year: | 2018 |
| Target Price: | $49.00 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $15.81 - $50.89 | Next Earning Date: | 04-30-2025 |
| Revenue: | $739,016,000 | Revenue Growth: | 31.04% |
| Revenue Growth (this year): | 19.33% | Revenue Growth (next year): | 21.67% |
Stock Insider Trading Activity of Guardant Health Inc. (GH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Tariq Musa | GH | Director | Mar 19 '25 | Sell | $43.70 | 116 | $5,069.20 | 3,211 | |
| Kalia Kumud | GH | Chief Information Officer | Mar 15 '25 | Sell | $43.16 | 3,500 | $151,060.35 | 19,720 | |
| Joyce Meghan V. | GH | Director | Mar 3 '25 | Sell | $42.71 | 100 | $4,271.00 | 7,647 | |
| Tariq Musa | GH | Director | Feb 20 '25 | Sell | $48.33 | 116 | $5,606.28 | 3,211 |
Latest Guardant Health Inc. News
GH Breaking Stock News: Dive into GH Ticker-Specific Updates for Smart Investing
Investor's Business Daily
a day ago
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
TipRanks
4 days ago
Guardant Health price target raised to $60 from $56 at BofA
MT Newswires
5 days ago
BofA Securities Raises Price Target on Guardant Health to $60 From $56, Keeps Buy Rating
Business Wire
8 days ago
Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
MT Newswires
9 days ago
Mizuho Initiates Guardant Health at Outperform
StockStory
11 days ago
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
Business Wire
16 days ago
Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
StockStory
18 days ago
3 Small-Cap Stocks in the Doghouse
Compare GH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GH Guardant Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.